Prospective risk stratification of sudden cardiac death in Marfan's syndrome

International Journal of Cardiology

Volumn 167, Issue 6, 2013, Pages 2539-2545

  Hoffmann, Boris A ^a   Rybczynski, Meike ^a   Rostock, Thomas ^b   Servatius, Helge ^a   Drewitz, Imke ^a   Steven, Daniel ^a   Aydin, Ali ^a   Sheikhzadeh, Sara ^a   Darko, Vivien ^a   Von Kodolitsch, Yskert ^a   Willems, Stephan ^a  

^a UNIVERSITY HEART CENTER HAMBURG   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Cardiomyopathy; Marfan syndrome; Natriuretic peptide; Sudden cardiac death; Ventricular arrhythmia

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; ARRHYTHMOGENIC SYNCOPE; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART RATE VARIABILITY; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; MARFAN SYNDROME; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESTING ELECTROCARDIOGRAM; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SIGNAL AVERAGED ELECTROCARDIOGRAPHY; SUDDEN CARDIAC DEATH; TRANSTHORACIC ECHOCARDIOGRAPHY;

CARDIOMYOPATHY; MARFAN SYNDROME; NATRIURETIC PEPTIDE; SUDDEN CARDIAC DEATH; VENTRICULAR ARRHYTHMIA;

ADULT; DEATH, SUDDEN, CARDIAC; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MARFAN SYNDROME; MIDDLE AGED; PROSPECTIVE STUDIES; RISK ASSESSMENT; YOUNG ADULT;

EID: 84883783561     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.06.036     Document Type: Article

References (43)

1. Y. von Kodolitsch, and M. Rybczynski Cardiovascular Aspects of the Marfan Syndrome P.N. Robinson, M. Godfrey, Marfan Syndrome: A Primer for Clinicians and Scientists 2004 Kluwer Academic New York, NY 45 69
2. R.B. Devereux, and M.J. Roman Aortic disease in Marfan's syndrome N Engl J Med 340 1999 1358 1359
3. A.T. Yetman, R.A. Bornemeier, and B.W. McCrindle Long-term outcome in patients with Marfan syndrome: is aortic dissection the only cause of sudden death? J Am Coll Cardiol 41 2003 329 332
4. M. Rybczynski, A.M. Bernhardt, and U. Rehder The spectrum of syndromes and manifestations in individuals screened for suspected Marfan syndrome Am J Med Genet A 146A 2008 3157 3166
5. A. De Paepe, R.B. Devereux, H.C. Dietz, R.C. Hennekam, and R.E. Pyeritz Revised diagnostic criteria for the Marfan syndrome Am J Med Genet 62 1996 417 426
6. G. Nijbroek, S. Sood, and I. McIntosh Fifteen novel FBN1 mutations causing Marfan syndrome detected by heteroduplex analysis of genomic amplicons Am J Hum Genet 57 1995 8 21
7. R.M. Lang, M. Bierig, and R.B. Devereux Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
8. J.S. Gottdiener, J. Bednarz, and R. Devereux American Society of Echocardiography recommendations for use of echocardiography in clinical trials J Am Soc Echocardiogr 17 2004 1086 1119
9. S.F. Nagueh, C.P. Appleton, and T.C. Gillebert Recommendations for the evaluation of left ventricular diastolic function by echocardiography J Am Soc Echocardiogr 22 2009 107 133
10. G. Breithardt, M.E. Cain, and N. el-Sherif Standards for analysis of ventricular late potentials using high-resolution or signal-averaged electrocardiography. A statement by a Task Force Committee of the European Society of Cardiology, the American Heart Association, and the American College of Cardiology Circulation 83 1991 1481 1488
11. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology Eur Heart J 17 1996 354 381
12. W.G. Stevenson, L.W. Stevenson, H.R. Middlekauff, and L.A. Saxon Sudden death prevention in patients with advanced ventricular dysfunction Circulation 88 1993 2953 2961
13. R. Sheldon, S. Rose, S. Connolly, D. Ritchie, M.L. Koshman, and M. Frenneaux Diagnostic criteria for vasovagal syncope based on a quantitative history Eur Heart J 27 2006 344 350
14. R.W. Jeremy, H. Huang, J. Hwa, H. McCarron, C.F. Hughes, and J.G. Richards Relation between age, arterial distensibility, and aortic dilatation in the Marfan syndrome Am J Cardiol 74 1994 369 373
15. A. Savolainen, L. Nisula, and P. Keto Left ventricular function in children with the Marfan syndrome Eur Heart J 15 1994 625 630
16. J.F. De Backer, D. Devos, and P. Segers Primary impairment of left ventricular function in Marfan syndrome Int J Cardiol 112 2006 353 358
17. M. Rybczynski, D.H. Koschyk, and M.A. Aydin Tissue Doppler imaging identifies myocardial dysfunction in adults with Marfan syndrome Clin Cardiol 30 2007 19 24
18. A. Kiotsekoglou, G.R. Sutherland, and J.C. Moggridge Impaired right ventricular systolic function demonstrated by reduced atrioventricular plane displacement in adults with Marfan syndrome Eur J Echocardiogr 10 2009 295 302
19. F. Ramirez, and H.C. Dietz Marfan syndrome: from molecular pathogenesis to clinical treatment Curr Opin Genet Dev 17 2007 252 258
20. A. Kiotsekoglou, G.R. Sutherland, J.C. Moggridge, D.K. Nassiri, A.J. Camm, and A.H. Child The unravelling of primary myocardial impairment in Marfan syndrome by modern echocardiography Heart 95 2009 1561 1566
21. M.J. Reiter Effects of mechano-electrical feedback: potential arrhythmogenic influence in patients with congestive heart failure Cardiovasc Res 32 1996 44 51
22. M.R. Franz, R. Cima, D. Wang, D. Profitt, and R. Kurz Electrophysiological effects of myocardial stretch and mechanical determinants of stretch-activated arrhythmias Circulation 86 1992 968 978
23. M. Rybczynski, D. Koschyk, and A. Karmeier Frequency of sleep apnea in adults with the Marfan syndrome Am J Cardiol 105 2010 1836 1841
24. P.A. Cistulli, H. Gotsopoulos, and C.E. Sullivan Relationship between craniofacial abnormalities and sleep-disordered breathing in Marfan's syndrome Chest 120 2001 1455 1460
25. P.A. Cistulli, and C.E. Sullivan Sleep apnea in Marfan's syndrome. Increased upper airway collapsibility during sleep Chest 108 1995 631 635
26. P.A. Cistulli, and C.E. Sullivan Influence of maxillary morphology on nasal airway resistance in Marfan's syndrome Acta Otolaryngol 120 2000 410 413
27. D. Yumino, H. Wang, and J.S. Floras Prevalence and physiological predictors of sleep apnea in patients with heart failure and systolic dysfunction J Card Fail 15 2009 279 285
28. M.T. Naughton, and G. Lorenzi-Filho Sleep in heart failure Prog Cardiovasc Dis 51 2009 339 349
29. A. Savolainen, M. Kupari, L. Toivonen, I. Kaitila, and M. Viitasalo Abnormal ambulatory electrocardiographic findings in patients with the Marfan syndrome J Intern Med 241 1997 221 226
30. D.L. Eckberg Parasympathetic cardiovascular control in human disease: a critical review of methods and results Am J Physiol 239 1980 H581 H593
31. D.J. Ewing Heart rate variability: an important new risk factor in patients following myocardial infarction Clin Cardiol 14 1991 683 685
32. J.T. Bigger Jr., P. Albrecht, R.C. Steinman, L.M. Rolnitzky, J.L. Fleiss, and R.J. Cohen Comparison of time- and frequency domain-based measures of cardiac parasympathetic activity in Holter recordings after myocardial infarction Am J Cardiol 64 1989 536 538
33. R.E. Kleiger, J.P. Miller, J.T. Bigger Jr., and A.J. Moss Decreased heart rate variability and its association with increased mortality after acute myocardial infarction Am J Cardiol 59 1987 256 262
34. R.E. Kleiger, J.P. Miller, R.J. Krone, and J.T. Bigger Jr. The independence of cycle length variability and exercise testing on predicting mortality of patients surviving acute myocardial infarction. The Multicenter Postinfarction Research Group Am J Cardiol 65 1990 408 411
35. E.J. Rashba, N.A. Estes, and P. Wang Preserved heart rate variability identifies low-risk patients with nonischemic dilated cardiomyopathy: results from the DEFINITE trial Heart Rhythm 3 2006 281 286
36. W. Grimm, M. Christ, J. Bach, H.H. Muller, and B. Maisch Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study Circulation 108 2003 2883 2891
37. T. Itou, S. Obata, and O. Tateishi Characteristics of the circadian rhythm of heart rate variability in patients with sudden cardiac death after myocardial infarction Ann Noninvasive Electrocardiol 3 1998 183 193
38. B. Lown, and R.L. Verrier Neural activity and ventricular fibrillation N Engl J Med 294 1976 1165 1170
39. B.J. Maron, W.C. Roberts, H.A. McAllister, D.R. Rosing, and S.E. Epstein Sudden death in young athletes Circulation 62 1980 218 229
40. B.J. Maron, J. Shirani, L.C. Poliac, R. Mathenge, W.C. Roberts, and F.O. Mueller Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles JAMA 276 1996 199 204
41. S. Chen, L.F. Fagan, S. Nouri, and J.L. Donahoe Ventricular dysrhythmias in children with Marfan's syndrome Am J Dis Child 139 1985 273 276
42. S.M. Straus, G.S. Bleumink, J.P. Dieleman, J. van der Lei, B.H. Stricker, and M.C. Sturkenboom The incidence of sudden cardiac death in the general population J Clin Epidemiol 57 2004 98 102
43. S. Sheikhzadeh, C. Kade, and B. Keyser Analysis of phenotype and genotype information for the diagnosis of Marfan syndrome Clin Genet 82 2012 240 247